# Spectroscopic and Diffusion Weighted Analysis of the Effects of Dexamethasone on High Altitude Cerebral Oedema (HACE)

> **NCT03341676** · PHASE1 · COMPLETED · sponsor: **University Hospitals Coventry and Warwickshire NHS Trust** · enrollment: 10 (actual)

## Conditions studied

- High Altitude Cerebral Edema

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03341676
- **Lead sponsor:** University Hospitals Coventry and Warwickshire NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-14
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03341676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03341676, "Spectroscopic and Diffusion Weighted Analysis of the Effects of Dexamethasone on High Altitude Cerebral Oedema (HACE)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03341676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*